Latest filings (excl ownership)
EFFECT
Notice of effectiveness
3 May 24
DEFA14A
Additional proxy soliciting materials
29 Apr 24
DEF 14A
Definitive proxy
29 Apr 24
ARS
2023 FY
Annual report to shareholders
29 Apr 24
8-K
ImmunityBio Announces FDA Approval of ANKTIVA®, First-in-Class
23 Apr 24
S-3ASR
Automatic shelf registration
17 Apr 24
S-3
Shelf registration
28 Mar 24
10-K
2023 FY
Annual report
19 Mar 24
8-K
Departure of Directors or Certain Officers
23 Feb 24
8-K
ImmunityBio Announces $320 Million Investment by Oberland
2 Jan 24
10-Q
2023 Q3
Quarterly report
8 Nov 23
DEF 14C
Information statement
28 Sep 23
D
$469.99 mm in equity / debt, sold $469.99 mm, 3 investors
22 Sep 23
PRE 14C
Preliminary information
15 Sep 23
8-K
ImmunityBio Announces $470 Million Equity and Debt Financing
11 Sep 23
8-K
Other Events
1 Sep 23
8-K
Other Events
15 Aug 23
10-Q
2023 Q2
Quarterly report
8 Aug 23
424B5
Prospectus supplement for primary offering
25 Jul 23
424B5
Prospectus supplement for primary offering
24 Jul 23
8-K
ImmunityBio Announces Execution of $40 Million Equity Financing with Institutional Investors
21 Jul 23
8-K
Other Events
20 Jul 23
8-K
Entry into a Material Definitive Agreement
14 Jun 23
10-Q
2023 Q1
Quarterly report
11 May 23
8-K
Other Events
11 May 23
DEFA14A
Additional proxy soliciting materials
28 Apr 23
DEF 14A
Definitive proxy
28 Apr 23
ARS
2022 FY
Annual report to shareholders
28 Apr 23
8-K
Entry into a Material Definitive Agreement
31 Mar 23
8-K
Other Events
20 Mar 23
10-K
2022 FY
Annual report
1 Mar 23
424B5
Prospectus supplement for primary offering
15 Feb 23
8-K
ImmunityBio Announces Execution of $50 Million Equity Financing with Multiple Institutional Investors
15 Feb 23
8-K
Results of Operations and Financial Condition
14 Feb 23
8-K
Other Events
13 Feb 23
EFFECT
Notice of effectiveness
10 Feb 23
CORRESP
Correspondence with SEC
8 Feb 23
UPLOAD
Letter from SEC
8 Feb 23
S-3
Shelf registration
6 Feb 23
UPLOAD
Letter from SEC
11 Jan 23
Latest ownership filings
4
Barry J. Simon
26 Feb 24
4
REGAN J LAUER
26 Feb 24
4
David C. Sachs
26 Feb 24
4
Richard Adcock
26 Feb 24
4
PATRICK SOON-SHIONG
26 Feb 24
4
Richard Adcock
6 Feb 24
4
Barry J. Simon
2 Feb 24
4
David C. Sachs
2 Feb 24
4
REGAN J LAUER
2 Feb 24
SC 13D/A
Cambridge Equities, LP
3 Jan 24
4
PATRICK SOON-SHIONG
3 Jan 24
4
David C. Sachs
3 Jan 24
4
Richard Adcock
3 Jan 24
4
REGAN J LAUER
19 Dec 23
SC 13D/A
Cambridge Equities, LP
21 Sep 23
4
PATRICK SOON-SHIONG
13 Sep 23
4
David C. Sachs
6 Sep 23
4
REGAN J LAUER
6 Sep 23
4
Barry J. Simon
6 Sep 23
4
Barry J. Simon
28 Aug 23
4
REGAN J LAUER
28 Aug 23
4
David C. Sachs
28 Aug 23
4
REGAN J LAUER
16 Jun 23
4
Christobel Selecky
15 Jun 23
4
LINDA MAXWELL
15 Jun 23
4
Cheryl Cohen
15 Jun 23
4
Wesley Clark
15 Jun 23
4
John Owen Brennan
15 Jun 23
4
MICHAEL D BLASZYK
15 Jun 23
4
MICHAEL D BLASZYK
5 Jun 23
4
John Owen Brennan
5 Jun 23
4
Wesley Clark
5 Jun 23
SC 13D/A
Cambridge Equities, LP
23 May 23
4
PATRICK SOON-SHIONG
16 May 23
3/A
Wesley Clark
1 Mar 23
4
Richard Adcock
7 Feb 23
4
David C. Sachs
4 Jan 23
4
Richard Adcock
4 Jan 23
4
PATRICK SOON-SHIONG
14 Dec 22
SC 13D/A
Cambridge Equities, LP
7 Dec 22